Gunnar Kaufmann
No más puestos en curso
Fortuna: 42 624 $ al 31/03/2024
Perfil
Gunnar F.
Kaufmann worked as Senior VP-Immunotherapy & Head-Research at Sorrento Therapeutics, Inc. from 2012 to 2019.
He then worked as Chief Scientific Officer at Oncternal Therapeutics, Inc. from 2019 to 2023.
Kaufmann holds a doctorate degree from The Scripps Research Institute, an undergraduate degree from Philipps University of Marburg, and a graduate degree from the University of Greifswald.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/06/2023 | 4 736 ( 0.16% ) | 42 624 $ | 31/03/2024 |
Antiguos cargos conocidos de Gunnar Kaufmann.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14/06/2023 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
Formación de Gunnar Kaufmann.
| The Scripps Research Institute | Doctorate Degree |
| Philipps University of Marburg | Undergraduate Degree |
| University of Greifswald | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Gunnar Kaufmann
